Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.
In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates, such as griseofulvin and digoxin, dissolve gradually in gastrointestinal fluids, ensuring sustained release. Some drugs, like ferrous sulfate, may transform into slower-dissolving forms when exposed to gastrointestinal fluids, extending their release. Another method involves embedding drugs in slowly dissolving matrices or coating them with slow-dissolving materials to regulate fluid penetration and delay drug release.
In diffusion-controlled DDS, the release rate is determined by the diffusion of dissolved drug molecules through a rate-controlling element rather than the dissolution of the drug or its surrounding matrix. This rate-controlling element is neither soluble, erodible, nor degradable but instead remains stable throughout the process. Materials commonly used for this purpose include water-swellable polymers such as xanthan gum, guar gum, high-viscosity grades of HPMC and HPC, and alginates. Alternatively, water-insoluble polymers like ethyl cellulose and polymethacrylates are frequently employed. These materials form a barrier that regulates drug diffusion, ensuring a steady and predictable release rate.
Dissolution-diffusion-controlled DDS combines both approaches by utilizing materials that influence both dissolution and diffusion processes. This hybrid design enhances release control by integrating features of slow-dissolving coatings with diffusion barriers, achieving improved precision in drug delivery.
By combining these methods, rate-programmed DDS systems provide flexible solutions for controlled drug release, enhancing therapeutic outcomes while reducing dosing frequency. This approach is particularly useful for medications that require prolonged absorption, ensuring better patient compliance and improved treatment efficiency.
Rate-programmed DDS release drugs at controlled rates using approaches such as polymeric matrix, reservoir, osmotic pump, and microchip systems. Rate-programmed drug delivery systems include various types.
In a dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug or the surrounding matrix.
Drugs with slow dissolution rates dissolve gradually, while others transform into slower-dissolving forms upon contact with GI fluids.
Another approach embeds drugs in slowly dissolving matrices or coats them with slow-dissolving materials to control fluid penetration.
In a diffusion-controlled DDS, the release rate depends on the diffusion of dissolved drug molecules through a rate-controlling element that is non-degradable and either water-swellable or insoluble.
Polymers such as xanthan gum, HPMC, and ethyl cellulose are commonly used in these drug delivery systems.
Dissolution and diffusion-controlled DDS combine both mechanisms, using materials that regulate drug release rate through dissolution and diffusion.
繁體中文
